Ostrand-Rosenberg; Suzanne

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ostrand-Rosenberg; Suzanne.The latest application filed is for "recombinant bi-specific polypeptide for coordinately activating tumor-reactive t-cells and neutralizing immune suppression".

Company Profile

0.11.11

Ostrand-Rosenberg; Suzanne - Columbia MD
Ostrand-Rosenberg; Suzanne - Baltimore MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Soluble CD80 as a therapeutic to reverse immune suppression in cancer patients Grant 10,377,810 - Ostrand-Rosenberg A	2019-08-13
Recombinant Bi-specific Polypeptide For Coordinately Activating Tumor-reactive T-cells And Neutralizing Immune Suppression App 20180291114 - Ostrand-Rosenberg; Suzanne ; et al.	2018-10-11
Soluble Cd80 As A Therapeutic To Reverse Immune Suppression In Cancer Patients App 20170226181 - OSTRAND-ROSENBERG; SUZANNE	2017-08-10
Soluble CD80 as a therapeutic to reverse immune suppression in cancer patients Grant 9,650,429 - Ostrand-Rosenberg May 16, 2	2017-05-16
Soluble Cd80 As A Therapeutic To Reverse Immune Suppression In Cancer Patients App 20150232532 - OSTRAND-ROSENBERG; SUZANNE	2015-08-20
Soluble CD80 as a therapeutic to reverse immune supression in cancer patients Grant 8,956,619 - Ostrand-Rosenberg February 17, 2	2015-02-17
Soluble Cd80 As A Therapeutic To Reverse Immune Supression In Cancer Patients App 20130149305 - OSTRAND-ROSENBERG; SUZANNE	2013-06-13
Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines Grant 8,444,965 - Ostrand-Rosenberg , et al. May 21, 2	2013-05-21
Tumor cells with increased immunogenicity and uses therfor Grant 8,026,224 - Ostrand-Rosenberg , et al. September 27, 2	2011-09-27
Tumor Cells From Immune Privileged Sites As Base Cells For Cell-based Cancer Vaccines App 20110165187 - Ostrand-Rosenberg; Suzanne ; et al.	2011-07-07
Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines Grant 7,807,186 - Ostrand-Rosenberg , et al. October 5, 2	2010-10-05
Methods For Diagnosing And Treating Cancer App 20100021472 - Srikrishna; Geetha ; et al.	2010-01-28
Tumor Cells From Immune Privileged Sites As Base Cells For Cell-based Cancer Vaccines App 20080206288 - Ostrand-Rosenberg; Suzanne ; et al.	2008-08-28
Tumor cells with increased immunogenicity and uses therfor App 20060099195 - Ostrand-Rosenberg; Suzanne ; et al.	2006-05-11
Tumor cells with increased immunogenicity and uses therefor App 20030124103 - Ostrand-Rosenberg, Suzanne ; et al.	2003-07-03
Tumor cells with increased immunogenicity and uses therefor App 20020086421 - Ostrand-Rosenberg, Suzanne ; et al.	2002-07-04
Tumor cells with increased immunogenicity and uses therefor Grant 6,319,709 - Ostrand-Rosenberg , et al. November 20, 2	2001-11-20
Tumor cells with increased immunogenicity and uses therefor Grant 6,149,905 - Ostrand-Rosenberg , et al. November 21, 2	2000-11-21
Tumor cells with increased immunogenicity and uses therefor Grant 5,858,776 - Ostrand-Rosenberg , et al. January 12, 1	1999-01-12

Company Registrations

NCAGE Code	47F92	OSTRAND-ROSENBERG SUZANNE
CAGE Code	47F92	OSTRAND-ROSENBERG, SUZANNE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.